Alcohol use disorder Trials in San Francisco, United States
Conditions / Alcohol use disorder / San Francisco, United States
Clinical trials for Alcohol use disorder investigate a range of treatment strategies and patient populations.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02252536 | HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder | COMPLETED | PHASE2 |
| NCT04769986 | Mobile Mindfulness for Alcohol Use and PTSD Among Veterans | COMPLETED | NA |
| NCT05191446 | Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use | ACTIVE_NOT_RECRUITING | NA |
| NCT02161718 | A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder | COMPLETED | PHASE2 |
| NCT05948605 | EMPOWER AUD Pivotal Trial | COMPLETED | NA |
| NCT04094584 | Emergency Department Initiated Extended-Release Naltrexone and Case Management for the Treatment of Alcohol Use Disorder | TERMINATED | PHASE4 |
| NCT03897348 | Pilot Human Lab Study of Lacosamide in Alcohol Use Disorder (AUD) | COMPLETED | PHASE2 |
| NCT07219953 | A Study of Brenipatide in Participants With Alcohol Use Disorder | RECRUITING | — |
| NCT03709043 | Addressing Heavy Alcohol Use Consumption With Kudzu | COMPLETED | — |
| NCT07219966 | A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder | RECRUITING | — |